---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-049371"
form_type: "8-K"
ticker: "PRPO"
cik: "0001043961"
company_name: "Precipio, Inc."
filed_at: "2025-05-15T23:59:59+00:00"
generated_at: "2026-05-21T04:22:27.615847+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Precipio Q1 revenue up 43% to $4.9M; adjusted EBITDA loss narrows 92% to $108K

## Summary
- Revenue $4.9M, +43% YoY; overall gross margin improved to 43% from 27%.
- Adjusted EBITDA loss of $108K vs $1.41M loss YoY, a 92% improvement.
- Cash used in operations was $44K vs $667K, improvement of 93%.
- Pathology Services rev +54%, test volume +46%; Products division onboarded 1 new customer, launched 2 panels.
- CEO expects positive operating cash flow in Q2 or Q3; Q2 received ~$400K CARES Act credit.

## SEC filing metadata
- accession: 0001104659-25-049371
- form_type: 8-K
- ticker: PRPO
- cik: 0001043961
- company_name: Precipio, Inc.
- filed_at: 2025-05-15T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1043961/000110465925049371/0001104659-25-049371-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1043961/000110465925049371/tm2515302d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-049371
- JSON: https://secwatch.observer/filing/0001104659-25-049371.json
- Plain text: https://secwatch.observer/filing/0001104659-25-049371.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.